Ekso Bionics Holdings, Inc. (EKSO)

NASDAQ: EKSO · IEX Real-Time Price · USD
1.48
-0.06 (-3.90%)
At close: Mar 28, 2023, 4:00 PM
1.43
-0.05 (-3.38%)
After-hours: Mar 28, 2023, 6:35 PM EDT
-3.9%
Market Cap 19.45M
Revenue (ttm) 13.44M
Net Income (ttm) -14.77M
Shares Out 13.14M
EPS (ttm) -1.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 27,007
Open 1.49
Previous Close 1.54
Day's Range 1.46 - 1.54
52-Week Range 1.03 - 2.95
Beta 1.76
Analysts Buy
Price Target 9.18 (+520.27%)
Earnings Date Apr 26, 2023

About EKSO

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provide... [Read more]

Sector Healthcare
Founded 2005
Employees 55
Stock Exchange NASDAQ
Ticker Symbol EKSO
Full Company Profile

Financial Performance

In 2021, EKSO's revenue was $11.25 million, an increase of 26.62% compared to the previous year's $8.88 million. Losses were -$9.76 million, -38.30% less than in 2020.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for EKSO stock is "Buy." The 12-month stock price forecast is $9.18, which is an increase of 520.27% from the latest price.

Price Target
$9.18
(520.27% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Ekso Bionics Reports Fourth Quarter and Year End 2022 Results

SAN RAFAEL, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today re...

13 hours ago - GlobeNewsWire

Ekso Bionics to Showcase Integrated Functional Electrical Stimulation for Indego Therapy at APTA Meeting

SAN RAFAEL, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced it will ...

1 month ago - GlobeNewsWire

Ekso Bionics (EKSO) Reports Q3 Loss, Lags Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of -37.50% and 7.01%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Ekso Bionics Reports Third Quarter 2022 Results

Quarterly Record of 33 EksoNR Bookings in Q3 2022

5 months ago - GlobeNewsWire

Ekso Bionics to Present at H.C. Wainwright 24th Annual Global Investment Conference

SAN RAFAEL, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today an...

7 months ago - GlobeNewsWire

Ekso Bionics (EKSO) Reports Q2 Loss, Misses Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of 4.17% and 0.72%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

Ekso Bionics Reports Second Quarter 2022 Results

RICHMOND, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today repor...

8 months ago - GlobeNewsWire

Ekso Bionics to Report Second Quarter 2022 Financial Results on July 28

RICHMOND, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today annou...

8 months ago - GlobeNewsWire

Ekso Bionics Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Multiple Sclerosis Patients

First FDA Cleared Exoskeleton for Rehabilitation Use in Patients with Multiple Sclerosis

10 months ago - GlobeNewsWire

Ekso Bionics Appoints Jerome Wong Interim Chief Financial Officer

RICHMOND, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announ...

10 months ago - GlobeNewsWire

Ekso Bionics (EKSO) Could Find Support Soon, Here's Why You Should Buy the Stock Now

Ekso Bionics (EKSO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among W...

11 months ago - Zacks Investment Research

Ekso Bionics (EKSO) Reports Q1 Loss, Lags Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of 12.20% and 19.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

11 months ago - Zacks Investment Research

Ekso Bionics Reports First Quarter 2022 Results

RICHMOND, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today repo...

11 months ago - GlobeNewsWire

Ekso Bionics to Report First Quarter 2022 Financial Results on April 28

RICHMOND, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today anno...

1 year ago - GlobeNewsWire

Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of 8% and 1.90%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Ekso Bionics to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022

RICHMOND, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today annou...

1 year ago - GlobeNewsWire

Ekso Bionics Announces Leadership Transition

Board Member Steven Sherman to be Appointed CEO

1 year ago - GlobeNewsWire

Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results

Company Achieves Record Quarterly Revenue of $3.9 million to $4.1 million 1

1 year ago - GlobeNewsWire

Ekso Bionics to Participate at the H.C. Wainwright BioConnect Virtual Conference

RICHMOND, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that manage...

1 year ago - GlobeNewsWire

Ekso Bionics Appoints Corinna E. Lathan, Ph.D.

RICHMOND, Calif., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today annou...

1 year ago - GlobeNewsWire

Ekso Bionics Announces EksoNR Multi-Unit Order by Nebraska Fraternal Order of Eagles

- Foundation Donates Units to Two Inpatient Rehabilitation Facilities in Nebraska -

1 year ago - GlobeNewsWire

Ekso Bionics (EKSO) Reports Q3 Loss, Tops Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of 32.00% and 18.18%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Ekso Bionics Reports Third Quarter 2021 Results

RICHMOND, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today repor...

1 year ago - GlobeNewsWire

Ekso Bionics to Report Third Quarter 2021 Financial Results on November 2, 2021

RICHMOND, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today annou...

1 year ago - GlobeNewsWire